Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the Company's own shares executed on September 19, 2025, and announced on September 22, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity under the second tranche of a buyback programme announced on July 31, 2025.
| Metric | Value |
|---|---|
| Total Shares Purchased | 4,150,000 |
| Share Price Range (pence) | 338.80 - 342.30 |
| Volume Weighted Average Price (pence) | 340.72 (LSE), 340.18 (CBOE) |
| Post-Transaction Treasury Shares | 23,037,545 |
| Registered Share Capital | 8,952,353,648 shares |
| Voting Shares Outstanding | 8,929,316,103 |
Material Changes
The primary material change is the reduction of outstanding voting shares by 4,150,000 due to the buyback. The purchased shares are held as treasury shares. No other material changes to operations or financial position are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed transaction.
Investor Verification Checklist
- Verify the total cost of the 4,150,000 shares purchased against the reported volume-weighted average prices.
- Confirm the updated number of voting shares (8,929,316,103) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular execution details.
- Check the Company's website for the full text of the buyback programme announced on July 31, 2025, to understand the remaining authorization.